Smoldering myeloma: state of the art

Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, talks on the current state of the art in the smoldering myeloma space. The need for improved markers and terminology is outlined as is the benefit of genomic sequencing. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).